Technical Analysis for TPST - Tempest Therapeutics, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| D | 3.38 | -0.59% | -0.02 |
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 20 DMA Resistance | Bearish | 0.00% | |
| Shooting Star Candlestick | Bearish | 0.00% | |
| 180 Bearish Setup | Bearish Swing Setup | 0.00% | |
| Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | 0.00% | |
| 20 DMA Resistance | Bearish | -0.59% | |
| 20 DMA Resistance | Bearish | 3.05% | |
| MACD Bearish Signal Line Cross | Bearish | 3.05% | |
| Inside Day | Range Contraction | 3.05% | |
| Fell Below 20 DMA | Bearish | 4.00% | |
| BB Squeeze Ended | Range Expansion | 4.00% |
| Alert | Time |
|---|---|
| Down 1% | about 16 hours ago |
| 60 Minute Opening Range Breakdown | about 16 hours ago |
| 20 DMA Resistance | about 17 hours ago |
| 10 DMA Resistance | about 17 hours ago |
| Rose Above 10 DMA | about 18 hours ago |
Get a Trading Assistant
- Earnings date: 06/13/2024
Tempest Therapeutics, Inc. Description
Tempest Therapeutics Inc., a clinical-stage oncology company, engages in developing small molecules that combine targeted and immune-mediated mechanisms with the potential to treat various tumors. The company's two novel clinical programs are TPST-1495 and TPST-1120, antagonists of EP2/EP4 and PPARa. Its TPST-1495 and TPST-1120 are advancing through Phase 1 studies designed to study agents as monotherapies and in combination with other approved agents. The company is also developing an orally-available inhibitor of TREX-1 designed to activate selectively the cGAS/STING pathway, an innate immune response pathway important for the development of anti-tumor immunity. The company is headquartered in South San Francisco, California. Tempest Therapeutics Inc. operates as a subsidiary of Inception Sciences, Inc.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Tumor
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 9.0 |
| 52 Week Low | 0.17 |
| Average Volume | 983,306 |
| 200-Day Moving Average | 3.05 |
| 50-Day Moving Average | 3.66 |
| 20-Day Moving Average | 3.44 |
| 10-Day Moving Average | 3.48 |
| Average True Range | 0.26 |
| RSI (14) | 45.05 |
| ADX | 12.17 |
| +DI | 20.68 |
| -DI | 19.42 |
| Chandelier Exit (Long, 3 ATRs) | 3.00 |
| Chandelier Exit (Short, 3 ATRs) | 3.85 |
| Upper Bollinger Bands | 3.76 |
| Lower Bollinger Band | 3.11 |
| Percent B (%b) | 0.41 |
| BandWidth | 18.97 |
| MACD Line | -0.08 |
| MACD Signal Line | -0.08 |
| MACD Histogram | -0.0055 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 3.73 | ||||
| Resistance 3 (R3) | 3.76 | 3.67 | 3.67 | ||
| Resistance 2 (R2) | 3.67 | 3.58 | 3.66 | 3.65 | |
| Resistance 1 (R1) | 3.53 | 3.53 | 3.48 | 3.50 | 3.63 |
| Pivot Point | 3.44 | 3.44 | 3.42 | 3.42 | 3.44 |
| Support 1 (S1) | 3.29 | 3.35 | 3.25 | 3.26 | 3.13 |
| Support 2 (S2) | 3.20 | 3.29 | 3.19 | 3.11 | |
| Support 3 (S3) | 3.06 | 3.20 | 3.09 | ||
| Support 4 (S4) | 3.03 |
